These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4330238

  • 21. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium.
    Torda TA, Foldes FF, Bailey RJ, Klonymus DH, Kuwabara S.
    Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacological studies of extraocular muscles.
    Katz RL, Eakins KE.
    Invest Ophthalmol; 1967 Jun; 6(3):261-8. PubMed ID: 6026354
    [No Abstract] [Full Text] [Related]

  • 23. Effect of various antibiotics on neuromuscular transmission.
    Dretchen KL, Gergis SD, Sokoll MD, Long JP.
    Eur J Pharmacol; 1972 May; 18(2):201-3. PubMed ID: 4338756
    [No Abstract] [Full Text] [Related]

  • 24. The potentiation of neuromuscular blocking agents by quinidine.
    Miller RD, Way WL, Katzung BG.
    Anesthesiology; 1967 May; 28(6):1036-41. PubMed ID: 4383426
    [No Abstract] [Full Text] [Related]

  • 25. Monitoring of neuromuscular function.
    Ali HH, Savarese JJ.
    Anesthesiology; 1976 Aug; 45(2):216-49. PubMed ID: 180849
    [No Abstract] [Full Text] [Related]

  • 26. Do maternally administered neuromuscular blocking agents interfere with fetal neuromuscular transmission?
    Evans CA, Waud DR.
    Anesth Analg; 1973 Aug; 52(4):548-52. PubMed ID: 4352149
    [No Abstract] [Full Text] [Related]

  • 27. Neuromuscular blocking agents. Replacement of quaternary ammonium groups in bis-onium compounds by amidinium, guanidinium, thiouronium, sulphonium and sulphoxonium groups.
    Bamford DG, Biggs DF, Chaplen P, Davis M.
    J Pharm Pharmacol; 1970 Feb; 22(2):110-5. PubMed ID: 4392244
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Blockade of adrenal medullary stimulation in cats by competitive & depolarizing neuromuscular blocking agents.
    Patnaik GK, Dhawan BN.
    Indian J Exp Biol; 1971 Jul; 9(3):362-4. PubMed ID: 5144335
    [No Abstract] [Full Text] [Related]

  • 33. Local electrographic responses to intrahippocampal d-tubocurarine and related neuromuscular blocking agents.
    Baker WW, Benedict F.
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):607-11. PubMed ID: 4225340
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. INFLUENCE OF CHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE AND ACETAZOLAMIDE ON NEUROMUSCULAR TRANSMISSION IN MAMMALS.
    GESSA GL, FERRARI W.
    Arch Int Pharmacodyn Ther; 1963 Jul 01; 144():258-68. PubMed ID: 14043650
    [No Abstract] [Full Text] [Related]

  • 40. [Pharmacological properties of a new antidepolarizing curare-like compound, diadonium diiodide].
    Kharkevich DA.
    Farmakol Toksikol; 1970 Jul 01; 33(5):531-6. PubMed ID: 4321817
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.